We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of General Psychiatry |

This Month in Archives of General Psychiatry FREE

Arch Gen Psychiatry. 2004;61(3):219. doi:10.1001/archpsyc.61.3.219.
Text Size: A A A
Published online

Uhl and GrowArticlehaveused estimates of the economic impact of prominent neuropsychiatric disordersin the United States, overall heritabilities, and single-gene inheritanceto calculate the effect of complex genetics in psychiatry and neurology. Thelarge effect of oligogenic and polygenic inherited influences motivates effortsto identify the gene variants involved for better prevention and treatment.

Palmer et alArticleevaluatedtreatment-related decisional capacity among middle-aged and older patientswith schizophrenia. Overall, patients with schizophrenia showed less understandingof treatment disclosures than healthy subjects. However, there was also considerableheterogeneity in decisional capacity among patients. Decisional capacity inpatients with schizophrenia was predicted not by demographic characteristicsor severity of psychopathology but by neuropsychological performance. Considerationof cognitive functions may be more relevant to patients' decisional capacitythan demographics or psychopathology.

Van der Stelt et alArticle assessedevent-related brain potentials (ERPs) in patients with schizophrenia and healthysubjects. Patients with schizophrenia displayed deficits in the P3 componentbut not in earlier-occurring sensory-evoked or cognitive-related ERP components.These findings suggest that high-level attention-dependent cognitive deficitscentral to schizophrenia do not originate from preceding deficits at lowerlevels of information processing.

Wade et alArticleusedopposite-sex and same-sex dizygotic twins to examine associations with bulimianervosa (BN) status in one twin with psychopathology in the co-twin. Familialor nonfamilial shared risk factors existed between BN and generalized anxietydisorder, neuroticism, psychoactive substance use, novelty seeking, majordepression, and panic disorder. The shared risk factors between BN and generalanxiety disorder and novelty seeking are only present in men, suggesting afamilial, sex-specific manifestation.

Nelson et alArticleexaminedthe genetic epidemiology of alcohol-induced blackouts in a young adult Australiantwin panel. They found the heritability of lifetime blackouts to be 53% andof having 3 or more blackouts in a year to be 58%. Models that controlledfor respondents' frequency of intoxication found evidence for a significantshared genetic contribution unique to risk for blackouts.

In the treatment of cocaine dependence, no effective pharmacologicalintervention has been identified. Carroll et alArticleconducted a randomized, placebo controlled, double-blindtrial comparing disulfiram with a placebo and cognitive behavioral therapywith interpersonal therapy. Results suggested that disulfiram and cognitivebehavioral therapy are effective therapies for cocaine-dependent individualsand that disulfiram may exert a direct effect on cocaine use rather than throughreducing concurrent alcohol use.

Weissman et alArticlefollowup findings from their genetic linkage study that suggested a possible panicdisorder (PD) syndrome, including bladder problems, thyroid disorders, chronicheadaches and migraine, and mitral valve prolapse. Patients with interstitialcystitis diagnosed by urodynamics or cystoscopy as compared with control subjectshad higher rates of PD and most of the other syndrome conditions as did theirfirst-degree relatives. The possibility of a familial pleiotropic syndromethat may include interstitial cystitis and PD deserves further investigation.

Children with fragile X (fraX) suffer from impaired social functioning,which often includes eye gaze aversion. Garrett et alArticleused functional magnetic resonance imaging to determinewhether individuals with fraX show aberrant brain activation in response toeye gaze and face stimuli. Individuals with fraX had decreased activationof the superior temporal sulcus compared with control subjects, indicatingdeficits in the perception of eye gaze. Subjects with fraX also lacked specificityof fusiform gyrus activation to face orientation, suggesting an absence ofthe normal preference for forward faces rather than angled faces.

In a 2-site neuroimaging study, Lotspeich et alArticleassessed possible neuroanatomical differences betweenAsperger disorder and autism to determine whether these conditions align themselvesalong a severity continuum or constitute distinct biological entities. Cerebralgray tissue volume findings suggest that Asperger disorder is at one end ofthe autism spectrum. However, exploratory assessments of brain-IQ relationshipsindicate neurodevelopmental differences between Asperger disorder and high-functioningautism.

Previous studies have provided evidence that bipolar disorder is associatedwith abnormalities of mitochondrial function, resulting in abnormal energymetabolism. Konradi et alArticle examinedmessenger RNA expression in the hippocampus of patients with bipolar disorderand schizophrenia using microarray technology. They found evidence for relativelyspecific decreased expression of genes regulating mitochondrial function insupport of the hypothesis of abnormal energy metabolism in bipolar disorder.

Gueorguieva and KrystalArticlereviewmethods for analysis of repeated measures data, illustrate the advantagesof mixed-effect models, and assess the extent of the shift from traditionalto mixed-effect approaches in published reports in the ARCHIVES.





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.